Oncology Drug Reference Sheet: Futibatinib | ONS Voice
Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors | Communications Chemistry
RCSB PDB - 6MZW: TAS-120 covalent complex with FGFR1
Futibatinib (TAS-120) | 99.92%(HPLC) | In Stock | FGFR inhibitor
Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors | Communications Chemistry
futibatinib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure - Kalyukina - 2019 - ChemMedChem - Wiley Online Library
RCSB PDB - 6MZW: TAS-120 covalent complex with FGFR1
Futibatinib | New Drug Approvals
PDF) TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma
Cancers | Free Full-Text | Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
FGFR Breast Cancer Clinical Trials - FGFR inhibitor - Massive Bio
Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma - ScienceDirect
Futibatinib (TAS-120) | FGFR Inhibitor | MedChemExpress
GZD824 overcomes FGFR1‐V561F/M mutant resistance in vitro and in vivo - Jiang - 2021 - Cancer Medicine - Wiley Online Library
TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure - Kalyukina - 2019 - ChemMedChem - Wiley Online Library
TAS-120 (futibatinib) - Drug Hunter
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma | NEJM
![PDF] The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a427baac70235eb08dc51d856b5a992f6da96a2/9-Table1-1.png "PDF] The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives | Semantic Scholar")
PDF] The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives | Semantic Scholar
TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure - Kalyukina - 2019 - ChemMedChem - Wiley Online Library
Potency of FIIN-2, TAS-120 and PRN1371 against FGFR gatekeeper... | Download Scientific Diagram
Futibatinib (Lytgobi) for cholangiocarcinoma: Trends in Pharmacological Sciences
Cancers | Free Full-Text | Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors | Communications Chemistry
